229 related articles for article (PubMed ID: 34492627)
61. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
62. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.
Korteweg MA; Veldhuis WB; Visser F; Luijten PR; Mali WP; van Diest PJ; van den Bosch MA; Klomp DJ
Invest Radiol; 2011 Jun; 46(6):370-6. PubMed ID: 21317792
[TBL] [Abstract][Full Text] [Related]
63. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
64. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
65. A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI.
Ohashi A; Kataoka M; Iima M; Kanao S; Honda M; Urushibata Y; Nickel MD; Kishimoto AO; Ota R; Toi M; Togashi K
Magn Reson Imaging; 2020 Sep; 71():154-160. PubMed ID: 32302738
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
67. Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.
Liu S; Ren R; Chen Z; Wang Y; Fan T; Li C; Zhang P
J Magn Reson Imaging; 2015 Sep; 42(3):779-87. PubMed ID: 25580585
[TBL] [Abstract][Full Text] [Related]
68. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
[TBL] [Abstract][Full Text] [Related]
69. Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis.
Chu W; Jin W; Liu D; Wang J; Geng C; Chen L; Huang X
Oncotarget; 2018 Jan; 9(6):7088-7100. PubMed ID: 29467952
[TBL] [Abstract][Full Text] [Related]
70. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
[TBL] [Abstract][Full Text] [Related]
71. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
72. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Liang X; Yu X; Gao T
Eur J Radiol; 2022 May; 150():110247. PubMed ID: 35290910
[TBL] [Abstract][Full Text] [Related]
73. Accuracy of multiparametric MRI in distinguishing the breast malignant lesions from benign lesions: a meta-analysis.
Zhu CR; Chen KY; Li P; Xia ZY; Wang B
Acta Radiol; 2021 Oct; 62(10):1290-1297. PubMed ID: 33059458
[TBL] [Abstract][Full Text] [Related]
74. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.
Marinovich ML; Sardanelli F; Ciatto S; Mamounas E; Brennan M; Macaskill P; Irwig L; von Minckwitz G; Houssami N
Breast; 2012 Oct; 21(5):669-77. PubMed ID: 22863284
[TBL] [Abstract][Full Text] [Related]
75. Feasibility of quantitative and volumetric enhancement measurement to assess tumor response in patients with breast cancer after early neoadjuvant chemotherapy.
Ding J; Xiao H; Deng W; Liu F; Zhu R; Ha R
J Int Med Res; 2021 Mar; 49(3):300060521991017. PubMed ID: 33682494
[TBL] [Abstract][Full Text] [Related]
76. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
Li B; Li Q; Chen C; Guan Y; Liu S
Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
[TBL] [Abstract][Full Text] [Related]
77. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
78. Diffusion-weighted imaging versus dynamic contrast-enhanced imaging for pre-operative diagnosis of deep myometrial invasion in endometrial cancer: A meta-analysis.
Wang LJ; Tseng YJ; Wee NK; Low JJH; Tan CH
Clin Imaging; 2021 Dec; 80():36-42. PubMed ID: 34224952
[TBL] [Abstract][Full Text] [Related]
79. Diagnostic performance of MRI in detecting locally recurrent soft tissue sarcoma: systematic review and meta-analysis.
Kwee RM; Kwee TC
Eur Radiol; 2022 Jun; 32(6):3915-3930. PubMed ID: 35020015
[TBL] [Abstract][Full Text] [Related]
80. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
